Targeted-Release Budesonide in Chinese Patients with IgA Nephropathy: A Real-World Retrospective Cohort Study.

Yang X, Luo M, Zhao S, Yuan Y, Chen H, Jiang X

Open source

DOI
10.2147/dddt.s637358
Published
2026
Container
Drug design, development and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/dddt.s637358,
  title = {Targeted-Release Budesonide in Chinese Patients with IgA Nephropathy: A Real-World Retrospective Cohort Study.},
  author = {Yang X and Luo M and Zhao S and Yuan Y and Chen H and Jiang X},
  year = {2026},
  journal = {Drug design, development and therapy},
  doi = {10.2147/dddt.s637358},
  url = {https://doi.org/10.2147/dddt.s637358}
}

RIS

TY  - JOUR
TI  - Targeted-Release Budesonide in Chinese Patients with IgA Nephropathy: A Real-World Retrospective Cohort Study.
AU  - Yang X
AU  - Luo M
AU  - Zhao S
AU  - Yuan Y
AU  - Chen H
AU  - Jiang X
PY  - 2026
JO  - Drug design, development and therapy
DO  - 10.2147/dddt.s637358
UR  - https://doi.org/10.2147/dddt.s637358
ER  - 

APA

X, Y., M, L., S, Z., Y, Y., H, C., & X, J. (2026). Targeted-Release Budesonide in Chinese Patients with IgA Nephropathy: A Real-World Retrospective Cohort Study.. Drug design, development and therapy. https://doi.org/10.2147/dddt.s637358

Source records